Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus sufentanil for postoperative pain after intestinal surgery in elderly patients
ChiCTR2000034823Phase 4Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine and sufentanil in postoperative pain (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Effective compression times of PCA pump within 24 hours. Started Aug 2020; status: recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000034823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034823.